LGC leads first international CBD ring trial
The trial demonstrates the capability of laboratories to measure cannabidiol and controlled cannabinoids in consumer products
The trial demonstrates the capability of laboratories to measure cannabidiol and controlled cannabinoids in consumer products
LGC has been working with NHS Test and Trace to support the UK's response to the pandemic
The AccuPlex SARS-CoV-2 molecular controls kit is designed to measure day-to-day assay performance and contains positive materials
The collaboration is the first larger scale production run of Apta-1 as a non-GMP material, intended for use in GLP toxicology studies
AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage
The acquisition aims to strengthen LGC’s existing product offering to the in vitro diagnostics sector
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
The expansion of the portfolio is said to include the first ever multi-allergen reference material kit containing five common allergens
The acquisition follows LGC’s recent acquisition of Toronto Research Chemicals
LGC's Global Supplements Testing Programme, Informed-Sport, Partners with Chemist Warehouse